156 related articles for article (PubMed ID: 7607137)
1. Dioxin activates HIV-1 gene expression by an oxidative stress pathway requiring a functional cytochrome P450 CYP1A1 enzyme.
Yao Y; Hoffer A; Chang CY; Puga A
Environ Health Perspect; 1995 Apr; 103(4):366-71. PubMed ID: 7607137
[TBL] [Abstract][Full Text] [Related]
2. Regulation of mouse CYP1A1 gene expression by dioxin: requirement of two cis-acting elements during induction.
Neuhold LA; Shirayoshi Y; Ozato K; Jones JE; Nebert DW
Mol Cell Biol; 1989 Jun; 9(6):2378-86. PubMed ID: 2548080
[TBL] [Abstract][Full Text] [Related]
3. Dioxin induces transcription of fos and jun genes by Ah receptor-dependent and -independent pathways.
Hoffer A; Chang CY; Puga A
Toxicol Appl Pharmacol; 1996 Nov; 141(1):238-47. PubMed ID: 8917696
[TBL] [Abstract][Full Text] [Related]
4. Mouse cytosolic class 3 aldehyde dehydrogenase (Aldh3a1): gene structure and regulation of constitutive and dioxin-inducible expression.
Vasiliou V; Reuter SF; Williams S; Puga A; Nebert DW
Pharmacogenetics; 1999 Oct; 9(5):569-80. PubMed ID: 10591537
[TBL] [Abstract][Full Text] [Related]
5. In vitro inhibition of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced activity by alpha-naphthoflavone and 6-methyl-1,3,8-trichlorodibenzofuran using an aryl hydrocarbon (Ah)-responsive construct.
Merchant M; Safe S
Biochem Pharmacol; 1995 Aug; 50(5):663-8. PubMed ID: 7669069
[TBL] [Abstract][Full Text] [Related]
6. Activation of transcription factors activator protein-1 and nuclear factor-kappaB by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Puga A; Barnes SJ; Chang C; Zhu H; Nephew KP; Khan SA; Shertzer HG
Biochem Pharmacol; 2000 Apr; 59(8):997-1005. PubMed ID: 10692565
[TBL] [Abstract][Full Text] [Related]
7. Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells.
Suh J; Jeon YJ; Kim HM; Kang JS; Kaminski NE; Yang KH
Toxicol Appl Pharmacol; 2002 Jun; 181(2):116-23. PubMed ID: 12051995
[TBL] [Abstract][Full Text] [Related]
8. Dioxin-inducible enhancer region upstream from the mouse P(1)450 gene and interaction with a heterologous SV40 promoter.
Neuhold LA; Gonzalez FJ; Jaiswal AK; Nebert DW
DNA; 1986 Oct; 5(5):403-11. PubMed ID: 3023000
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of CYP1A1 gene expression in MCF-7 human breast cancer cells cotreated with 2,3,7,8-tetrachlorodibenzo-p-dioxin and 12-O-tetradecanoylphorbol-13-acetate.
Moore M; Narasimhan TR; Steinberg MA; Wang X; Safe S
Arch Biochem Biophys; 1993 Sep; 305(2):483-8. PubMed ID: 8396892
[TBL] [Abstract][Full Text] [Related]
10. Cell-specific regulation of human CYP1A1 and CYP1B1 genes.
Kress S; Greenlee WF
Cancer Res; 1997 Apr; 57(7):1264-9. PubMed ID: 9102211
[TBL] [Abstract][Full Text] [Related]
11. Expression of the chloramphenicol acetyltransferase (CAT) reporter gene by the murine Cyp1a-2 (cytochrome P3(450)) promoter in hepatoma cell cultures.
Owens RA; Nebert DW
Biochem Biophys Res Commun; 1990 Nov; 172(3):1109-15. PubMed ID: 2173915
[TBL] [Abstract][Full Text] [Related]
12. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
[TBL] [Abstract][Full Text] [Related]
13. Regulation of NF-kappaB and HIV-1 LTR activity in mouse L cells by ultraviolet radiation: LTR trans-activation in a nonirradiated genome in heterokaryons.
Miller SC; Taylor A; Watanabe K; Mok K; Torti FM
Exp Cell Res; 1997 Jan; 230(1):9-21. PubMed ID: 9013701
[TBL] [Abstract][Full Text] [Related]
14. Different response of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB 231 cells.
Döhr O; Vogel C; Abel J
Arch Biochem Biophys; 1995 Aug; 321(2):405-12. PubMed ID: 7646066
[TBL] [Abstract][Full Text] [Related]
15. Aryl hydrocarbon receptor activation in genital tubercle, palate, and other embryonic tissues in 2,3,7, 8-tetrachlorodibenzo-p-dioxin-responsive lacZ mice.
Willey JJ; Stripp BR; Baggs RB; Gasiewicz TA
Toxicol Appl Pharmacol; 1998 Jul; 151(1):33-44. PubMed ID: 9705885
[TBL] [Abstract][Full Text] [Related]
16. Disruption of dioxin-inducible phase I and phase II gene expression patterns by cadmium, chromium, and arsenic.
Maier A; Dalton TP; Puga A
Mol Carcinog; 2000 Aug; 28(4):225-35. PubMed ID: 10972992
[TBL] [Abstract][Full Text] [Related]
17. Dioxin suppresses benzo[a]pyrene-induced mutations and DNA adduct formation through cytochrome P450 1A1 induction and (±)-anti-benzo[a]pyrene-7,8-diol-9,10-epoxide inactivation in human hepatoma cells.
Shiizaki K; Kawanishi M; Yagi T
Mutat Res; 2013 Jan; 750(1-2):77-85. PubMed ID: 23036853
[TBL] [Abstract][Full Text] [Related]
18. 2,3,7,8-Tetrachlorodibenzo-p-dioxin's suppression of 1-nitropyrene-induced p53 expression is mediated by cytochrome P450 1A1.
Su JG; Huang MC; Chen FY
Chem Res Toxicol; 2011 Dec; 24(12):2167-75. PubMed ID: 22044530
[TBL] [Abstract][Full Text] [Related]
19. Regulation of NAD(P)H:quinone oxidoreductase 1 gene expression by CYP1A1 activity.
Marchand A; Barouki R; Garlatti M
Mol Pharmacol; 2004 Apr; 65(4):1029-37. PubMed ID: 15044633
[TBL] [Abstract][Full Text] [Related]
20. Dioxin-responsive genes: examination of dose-response relationships using quantitative reverse transcriptase-polymerase chain reaction.
Vanden Heuvel JP; Clark GC; Kohn MC; Tritscher AM; Greenlee WF; Lucier GW; Bell DA
Cancer Res; 1994 Jan; 54(1):62-8. PubMed ID: 8261464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
